Global Travelers Vaccines Market Research Report 2021

1 Travelers Vaccines Market Overview

• 1.1 Product Overview and Scope of Travelers Vaccines
• 1.2 Travelers Vaccines Segment by Type
  • 1.2.1 Global Travelers Vaccines Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Meningococcal Vaccine
  • 1.2.3 Japanese Encephalitis Vaccine
  • 1.2.4 Yellow Fever Vaccine
  • 1.2.5 Hepatitis Vaccine
  • 1.2.6 Cholera Vaccine
  • 1.2.7 Other
• 1.3 Travelers Vaccines Segment by End Users
  • 1.3.1 Global Travelers Vaccines Sales Comparison by End Users: (2021-2027)
  • 1.3.2 Tourists
  • 1.3.3 Students
  • 1.3.4 Workers
  • 1.3.5 Others
• 1.4 Global Travelers Vaccines Market Size Estimates and Forecasts
  • 1.4.1 Global Travelers Vaccines Revenue 2016-2027
  • 1.4.2 Global Travelers Vaccines Sales 2016-2027
  • 1.4.3 Travelers Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Travelers Vaccines Market Competition by Manufacturers

• 2.1 Global Travelers Vaccines Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Travelers Vaccines Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Travelers Vaccines Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Travelers Vaccines Manufacturing Sites, Area Served, Product Type
• 2.5 Travelers Vaccines Market Competitive Situation and Trends
  • 2.5.1 Travelers Vaccines Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Travelers Vaccines Players Market Share by Revenue
  • 2.5.3 Global Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Travelers Vaccines Retrospective Market Scenario by Region

• 3.1 Global Travelers Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Travelers Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Travelers Vaccines Market Facts & Figures by Country
  • 3.3.1 North America Travelers Vaccines Sales by Country
  • 3.3.2 North America Travelers Vaccines Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Travelers Vaccines Market Facts & Figures by Country
  • 3.4.1 Europe Travelers Vaccines Sales by Country
  • 3.4.2 Europe Travelers Vaccines Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Travelers Vaccines Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Travelers Vaccines Sales by Region
  • 3.5.2 Asia Pacific Travelers Vaccines Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Travelers Vaccines Market Facts & Figures by Country
  • 3.6.1 Latin America Travelers Vaccines Sales by Country
  • 3.6.2 Latin America Travelers Vaccines Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Travelers Vaccines Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Travelers Vaccines Sales by Country
  • 3.7.2 Middle East and Africa Travelers Vaccines Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Travelers Vaccines Historic Market Analysis by Type

• 4.1 Global Travelers Vaccines Sales Market Share by Type (2016-2021)
• 4.2 Global Travelers Vaccines Revenue Market Share by Type (2016-2021)
• 4.3 Global Travelers Vaccines Price by Type (2016-2021)

5 Global Travelers Vaccines Historic Market Analysis by End Users

• 5.1 Global Travelers Vaccines Sales Market Share by End Users (2016-2021)
• 5.2 Global Travelers Vaccines Revenue Market Share by End Users (2016-2021)
• 5.3 Global Travelers Vaccines Price by End Users (2016-2021)

6 Key Companies Profiled

• 6.1 GlaxoSmithKline
  • 6.1.1 GlaxoSmithKline Corporation Information
  • 6.1.2 GlaxoSmithKline Description and Business Overview
  • 6.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
  • 6.1.5 GlaxoSmithKline Recent Developments/Updates
• 6.2 Sanofi Pasteur
  • 6.2.1 Sanofi Pasteur Corporation Information
  • 6.2.2 Sanofi Pasteur Description and Business Overview
  • 6.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
  • 6.2.5 Sanofi Pasteur Recent Developments/Updates
• 6.3 Merck
  • 6.3.1 Merck Corporation Information
  • 6.3.2 Merck Description and Business Overview
  • 6.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Merck Travelers Vaccines Product Portfolio
  • 6.3.5 Merck Recent Developments/Updates
• 6.4 Pfizer
  • 6.4.1 Pfizer Corporation Information
  • 6.4.2 Pfizer Description and Business Overview
  • 6.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Pfizer Travelers Vaccines Product Portfolio
  • 6.4.5 Pfizer Recent Developments/Updates
• 6.5 CNBG
  • 6.5.1 CNBG Corporation Information
  • 6.5.2 CNBG Description and Business Overview
  • 6.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 CNBG Travelers Vaccines Product Portfolio
  • 6.5.5 CNBG Recent Developments/Updates
• 6.6 Sanofi Pasteur MSD
  • 6.6.1 Sanofi Pasteur MSD Corporation Information
  • 6.6.2 Sanofi Pasteur MSD Description and Business Overview
  • 6.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
  • 6.6.5 Sanofi Pasteur MSD Recent Developments/Updates
• 6.7 Serum Institute of India
  • 6.6.1 Serum Institute of India Corporation Information
  • 6.6.2 Serum Institute of India Description and Business Overview
  • 6.6.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Serum Institute of India Travelers Vaccines Product Portfolio
  • 6.7.5 Serum Institute of India Recent Developments/Updates
• 6.8 Biokangtai
  • 6.8.1 Biokangtai Corporation Information
  • 6.8.2 Biokangtai Description and Business Overview
  • 6.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Biokangtai Travelers Vaccines Product Portfolio
  • 6.8.5 Biokangtai Recent Developments/Updates

7 Travelers Vaccines Manufacturing Cost Analysis

• 7.1 Travelers Vaccines Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Travelers Vaccines
• 7.4 Travelers Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Travelers Vaccines Distributors List
• 8.3 Travelers Vaccines Customers

9 Travelers Vaccines Market Dynamics

• 9.1 Travelers Vaccines Industry Trends
• 9.2 Travelers Vaccines Growth Drivers
• 9.3 Travelers Vaccines Market Challenges
• 9.4 Travelers Vaccines Market Restraints

10 Global Market Forecast

• 10.1 Travelers Vaccines Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Travelers Vaccines by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Travelers Vaccines by Type (2022-2027)
• 10.2 Travelers Vaccines Market Estimates and Projections by End Users
  • 10.2.1 Global Forecasted Sales of Travelers Vaccines by End Users (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Travelers Vaccines by End Users (2022-2027)
• 10.3 Travelers Vaccines Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Travelers Vaccines by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Travelers Vaccines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List